US Patent 8048434 Vaccine adjuvants
Patent 8048434 was granted and assigned to Cadila Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+213 characters)
Article
Patent abstract
The invention relates to a novel adjuvant Mycobacterium w and or its constituents and adjuvant containing composition, which contains antigen (s) with pharmaceutical acceptable carrier and its uses.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Bakulesh Mafatlal Khamar0
Indravadan Ambalal Modi0
Nirav Desai0
Prasanta Kumar Ghosh0
Rajiv Indravadan Modi0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08048434 Vaccine adjuvants US Patent 8048434 Vaccine adjuvants
Infobox
Patent Number
080484340
Patent Number
80484340
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080484340
Date of Patent
November 1, 2011
0Patent Application Number
105837310
Date Filed
April 21, 2006
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08048434 Vaccine adjuvants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08048434
Date of patent
November 1, 2011
Patent application number
10583731
Date Filed
April 21, 2006
Patent primary examiner
Find more entities like US Patent 8048434 Vaccine adjuvants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.